THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY
FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 APRIL 2025
Charity number 1194038
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY
FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 APRIL 2025
| Contents | Page |
|---|---|
| Report of the Trustees | 1-4 |
| Independent Examiner’s Report | 5 |
| Statement of Financial Activities | 6 |
| Balance Sheet | 7 |
| Notes to the Accounts | 8-10 |
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2025
The trustees present their report and the independently examined financial statements of the Charitable Incorporated Organisation (number 1194038) for the year ended 30 April 2025.
The trustees who served during the year and to the date of this report were:
Dr Kenneth Poss Dr Jeffry Mumm Dr Henry Hamilton Roehl (resigned 30 September 2025) Dr Elly Tanaka Dr Phillip Newmark Dr Mekayla Storer (appointed 30 September 2025)
Registered Office School of Biosciences University of Sheffield Firth Court, Western Bank Sheffield South Yorkshire S10 2TN
Bankers Wise Business Independent JCS Accountants Limited 56 Shoreditch High Street Examiners 5 Robin Hood Lane London Sutton, Surrey E1 6JJ SM1 2SW United Kingdom
Solicitors Radcliffes Le Brasseur 5 Great College Street Westminster London SW1P 3SJ
Page 1
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY (ISRB)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2025
Objectives and Activities
Summary of the ISRB purposes
The promotion of the science of Regenerative Biology, in particular but not exclusively, through the delivery of an annual conference and associated workshops for the public benefit. The Trustees confirm that they have complied with the duty in section 17 of the Charities Act 2011 to have due regard to public benefit guidance published by the Charity Commission.
Summary of activities
1) We held our annual membership meeting in partnership with the EMBO Workshop “The molecular and cellular basis of regeneration and tissue repair” 07 – 11 October 2024 in Saint-Jean-Cap-Ferrat, France. Our annual prize ceremony was held at this event.
This year we provided two grants for the ISRB Speaker Awards. These awards help offset the travel costs for the sponsored speaker.
-
Dr. Ashley Seifert (University of Kentucky), "Building and Rebuilding Complex Tissues", 18-19th July, Cambridge, England
-
Dr. Andras Simon (Karolinska Institute), "Emerging Leaders in Regenerative Biology and Development", August 4-17th at the MDI Biological Laboratory, Maine, USA.
We run a trainee-only network webinar series which meets twice a month via Zoom.
We awarded two regenerative biology awards to distinguished research scientists and have organized two to three webinars a month with attendance of 20-80. These webinars are held in three time zones to include attendees from around the world.
All ISRB activities are open to members and non-members alike.
ISRB Executive Committee (the Trustees) and Advisory Board Meetings
ISRB’s executive board met quarterly from May of 2024 to April of 2025. Their meetings covered expenses, outreach, meeting planning, and advertising. The Trustees have worked throughout to carry out the ISRB’s purposes for the public benefit.
Achievements and Performance
ISRB Webinar Committee
ISRB has held three monthly webinars consistently over the past year with a webinar per specified time zone. Zone 1 webinar, the first week of the month for East and South Asia. Zone 2 webinar, the second week of the month for Europe, West Asia, and Africa. Zone 3 webinar, the third week of the month for The Americas. The webinar committee has grown from a group of five overseeing the monthly event to three committees to manage individual zones. These webinars are open to members and non-members alike.
ISRB Awards
ISRB was pleased to be able to offer prestigious awards (presented in the form of a medal) in two distinct categories.
The ISRB Rising Star Award is presented to those who are determined to be deserving of a young investigator award based on recommendations from two peers which highlights authored impactful publications and their scientific significance, the originality of their research program and independence in regenerative biology. Nominees must be within 7 years of starting an independent research group. Nominators must be ISRB members, but nominees need not be. Self-nominations are not accepted.
Page 2
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY (ISRB)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2025 (continued)
The ISRB Distinguished Achievement Award is presented to those that have shaped regenerative biology research through lasting and impactful scientific contributions. Nominations should be cosigned by two peers who can speak to the nominee’s scientific contributions, achievements, and impact in the field of regenerative biology. The nominators should explain why the nominee is deserving of this award, can reference up to five impactful publications, their scientific significance, and their impact on the scientific community through their mentorship, leadership, community service, outreach, and advocacy. Nominees need not have an active research program. Nominators must be ISRB members, but nominees need not be. Self-nominations are not accepted.
Three awards to scientists in the field of regenerative biology have been made this year:
ISRB Rising Star Award to Daniel Wehner , PhD, Group Leader, Max Planck Institute for the Science of Light, Germany and Junsu Kang, PhD, Associate Professor of Cell and Regenerative Biology, University of Wisconsin, USA
ISRB Distinguished Achievement Award to Helen Blau, PhD, Donald E. and Delia B. Baxter Foundation Professor, Stanford University, USA
Summary of the ISRB beneficiaries
ISRB provides a much-needed platform for the dissemination of research findings and the education of researchers and the public.
Financial Review
This year, the ISRB has raised £11,000 in membership fees. The primary annual membership fees are £75 for standard membership, £35 for post-doctoral membership and £20 for student members. Approximately half of the members have the standard membership with post-doctoral membership and student members making up one quarter each. The ISRB currently holds £83,681 in reserve in case unforeseen circumstances (for example cancellation of an ISRB event).
Structure, governance and management
Organisation
The ISRB has a CIO structure and the constitution is available at www.isrbio.org. In September 2023, the membership elected a new Chair-elect and a new Treasurer (to replace Sabine Eming who stepped down). Also in September Ken Poss became the Past-Chair and Elly Tanaka became Chair as part of the normal progression.
There are currently 5 Trustees including a Chair (Elly Tanaka), Chair-elect (Phillip Newmark), Past-Chair (Ken Poss), Treasurer (Jeff Mumm) and Secretary (Henry Roehl).
The appointment of Trustees is detailed below:
(1) The terms of the Trustees are as follows:
-
(a) Four years for the Treasurer and Secretary
-
(b) The Chair Elect will serve for two years, then progress to Chair for two years and then become Past Chair for two years. Thus, each Chair will serve a total of six years as a Trustee.
(2) The Secretary, Treasurer and Chair Elect are elected by balloting the Membership of the CIO.
(3) Candidates must have Membership in the CIO and be nominated and seconded by existing Members. These nominations must be provided to the Secretary twenty-one days in advance of the balloting date. The nominator must confirm that the candidate is willing to serve for the full term.
- (4) May not serve as a Trustee for more than four years, except the Chair Elect who will serve for six years.
Page 3
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY (ISRB)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2025 (continued)
(5) Any Trustee vacancy other than by annual retirement shall be appointed directly by the remaining Trustees.
Information for new Trustees
New Trustees shall receive a copy of the ISRB constitution and any amendments made to it and a copy of the CIO’s latest annual report and statement of accounts.
Arrangements of setting pay and remuneration for trustees
Trustees have not received pay but may be reimbursed for expenses that are incurred while performing charity work.
Decision making
Decisions involving the running of the charity are made during meetings of the Trustees, with input from the Advisory Board. Important decisions, such as amendments to the constitution, shall be made by balloting the membership as described in the constitution.
Statement of Trustee’s Responsibilities
The trustees are responsible for preparing the Trustees’ Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that period. In preparing these financial statements, the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP;
-
make judgments and estimates that are reasonable and prudent;
-
state whether applicable accounting standards have been followed, subject to any material
-
departures disclosed and explained in the financial statements; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.
The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
By order of the Board on 23 February 2026
Dr Mekayla Storer Trustee (Secretary)
Page 4
INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES OF THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY
I report to the charity trustees on my examination of the accounts of the International Society for Regenerative Biology for the year ended 30 April 2025.
Responsibilities and basis of report
As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).
I report in respect of my examination of the Trust’s accounts as carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner’s statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the Trust as required by section 130 of the Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Report) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Paul Newton FCA JCS Accountants Limited
5 Robin Hood Lane Sutton Surrey SM1 2SW
Date: 25 February 2026
Page 5
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY
STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 30 APRIL 2025
| Unrestricted | Unrestricted | |
|---|---|---|
| 2025 | 2024 | |
| £ | £ | |
| Income from | ||
| Charitable activities | ||
| Fee Income | 10,737 | 18,485 |
| Grants Received | - | 15,995 |
| Conference Income | - | 54,011 |
| Other Income | 421 | 11,478 |
| Total income | 11,158 | 99,969 |
| Expenditure on | ||
| Charitable activities | ||
| Conference expenses | - | 34,568 |
| Advertising | - | 1,000 |
| Bank Charges | 543 | 2,217 |
| Grants to individuals | 10,823 | 9,591 |
| Independent Examination and accounting | 2,280 | 2,136 |
| IT Support | 1,974 | 2,103 |
| Subscriptions | 1,130 | 3,948 |
| Investment losses | 1,016 | - |
| Foreign exchange losses | 1,201 | 709 |
| Total expenditure | 18,967 | 56,272 |
| Net (expenditure)/income and movement in funds | ( 7,809) | 43,697 |
| Reconciliation of funds | ||
| Unrestricted fund balance brought forward | 91,490 | 47,793 |
| Unrestricted fund balance carried forward | 83,681 | 91,490 |
Page 6
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY
BALANCE SHEET AS AT 30 APRIL 2025
| Note Fixed assets Investments 2 Current assets Cash at bank and in hand Creditors: Amounts falling due within one year 3 Net current assets Creditors: Amounts falling due In more than one year 4 Total Net assets Unrestricted Funds 5 |
£ 77,402 (10,955) |
2025 £ 17,984 66,447 ( 750) 83,681 83,681 |
£ 99,361 ( 7,496) |
2024 £ - 91,865 ( 375) 91,490 91,490 |
|---|---|---|---|---|
The financial statements were approved by the Board on 23 of February 2026 and signed on their behalf by:
Dr Jeffry Mumm Trustee (Treasurer)
Page 7
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 30 APRIL 2025
1 ACCOUNTING POLICIES
(a) Basis of accounting
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”), “Accounting and Reporting by Charities” the Statement of Recommended Practice for charities applying FRS 102, the Charities Act 2011 and UK Generally Accepted Accounting Practice. The charity meets the definition of a public benefit entity under FRS 102.
The financial statements are prepared in pounds sterling rounded to the nearest pound.
The financial statements have been prepared under the historical cost convention.
(b) Going concern
At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
(c) Income recognition
Fee and other income are included in the Statement of Financial Activities (SOFA) when the charity has entitlement to the income, it is probable the income will be received and the amount of income receivable can be reliably measured.
Revenue grants are accounted for on an accruals basis, matching it to the actual projects undertaken in the period rather than uniformly over the grant period.
Income received from delegates and sponsors for courses are recorded in the year the course takes place.
(d) Expenditure recognition
All expenditure is accrued as soon as a liability is considered probable, discounted to present value for longer term liabilities and has been classified under headings that aggregate all costs related to the category.
Charitable activities comprise expenditure directly related to the objects of the charity, including administration and support functions including any related provisions. It also includes governance costs, which comprise expenditure to comply with statutory and legal requirements
(e) Irrecoverable VAT
Irrecoverable VAT is included with the expense upon which it is incurred.
(f) Transactions in foreign currencies
Transactions in foreign currencies are translated into sterling at the exchange rate ruling at the date of the transaction. Assets and liabilities at the balance sheet date are translated into sterling at the rate ruling at the balance sheet date. All resultant differences arising from the above policy are dealt with in the Statement of Financial Activities.
Page 8
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 30 APRIL 2025 (continued)
1 ACCOUNTING POLICIES (CONTINUED)
(g) Cash at bank and in hand
Cash at bank and in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of opening of the deposit.
(h) Creditors and provisions
Creditors and provisions are recognised where the charity has a present obligation arising from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are recognised at their settlement amount
(i) Financial instruments
The charity only has financial assets and liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.
2 FIXED ASSETS INVESTMENTS
| Fair value As at 1 May Additions Disposals Net gains/(losses) on investments As at 30 April Historic cost As at 30 April |
2025 £ - 19,000 - ( 1,016) 17,984 19,000 |
2024 £ - - - - - - |
|---|---|---|
All investments are held in CAF ESG Growth Fund.
3 CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
| Accruals Deferred income |
2025 £ 2,280 8,675 10,955 |
2024 £ 2,136 5,360 7,496 |
|---|---|---|
4 CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Deferred income | 750 | 375 |
Page 9
THE INTERNATIONAL SOCIETY FOR REGENERATIVE BIOLOGY
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 30 APRIL 2025 (continued)
5 MOVEMENT ON FUNDS
| MOVEMENT ON FUNDS | ||||
|---|---|---|---|---|
| At | Total | Total | At | |
| 1 May | Income | Expenditure | 30 April | |
| 2024 | 2025 | |||
| £ | £ | £ | £ | |
| Unrestricted Funds | ||||
| General Fund | 91,490 | 11,158 | (18,967) | 83,681 |
| At | Total | Total | At | |
| 1 May | Income | Expenditure | 30 April | |
| 2023 | 2024 | |||
| £ | £ | £ | £ | |
| Unrestricted Funds | ||||
| General Fund | 47,793 | 99,969 | (56,272) | 91,490 |
6 RELATED PARTY TRANSACTIONS
None of the trustees or key management personnel received any remuneration or benefits in respect of services provided during this or the preceding financial year.
There are no other related party transactions.
Page 10